Author + information
- Scott T. Chiesa, PhDa,
- Marietta Charakida, MDa,b,
- Georgios Georgiopoulos, MDc,
- Frida Dangardt, MDa,d,
- Kaitlin H. Wade, PhDe,f,
- Alicja Rapala, BAa,j,
- Devina J. Bhowruth, BSca,
- Helen C. Nguyen, BSca,
- Vivek Muthurangu, MDg,
- Rukshana Shroff, MDa,h,
- George Davey Smith, MDe,f,
- Debbie A. Lawlor, MBChBe,f,
- Naveed Sattar, MDi,
- Nicholas J. Timpson, PhDe,f,
- Alun D. Hughes, PhDj,k and
- John E. Deanfield, MB BChira,∗ ()
- aVascular Physiology Unit, UCL Institute of Cardiovascular Science, London, United Kingdom
- bDivision of Imaging Sciences and Biomedical Engineering, King’s College London, United Kingdom
- c1st Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece
- dDepartment of Paediatric Physiology, The Queen Silvia Children’s Hospital, The Sahlgrenska Academy and University Hospital, Gothenburg, Sweden
- eMRC Integrative Epidemiology Unit (IEU), The University of Bristol, United Kingdom
- fPopulation Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, United Kingdom
- gCentre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, London, United Kingdom
- hNephrology Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- iInstitute of Cardiovascular and Medical Science, University of Glasgow, United Kingdom
- jDepartment of Population Science and Experimental Medicine, UCL Institute of Cardiovascular Science, London, United Kingdom
- kMRC Unit for Lifelong Health and Ageing at UCL, London, United Kingdom
- ↵∗Address for correspondence:
Prof. John Deanfield, UCL Institute of Cardiovascular Science, 1 St. Martin’s Le Grand, London EC1A 4NP, United Kingdom.
Objectives This study characterized the determinants of carotid intima-media thickness (cIMT) in a large (n > 4,000) longitudinal cohort of healthy young people age 9 to 21 years.
Background Greater cIMT is commonly used in the young as a marker of subclinical atherosclerosis, but its evolution at this age is still poorly understood.
Methods Associations between cardiovascular risk factors and cIMT were investigated in both longitudinal (ages 9 to 17 years) and cross-sectional (ages 17 and 21 years) analyses, with the latter also related to other measures of carotid structure and stress. Additional use of ultra-high frequency ultrasound in the radial artery at age 21 years allowed investigation of the distinct layers (i.e., intima or media) that may underlie observed differences.
Results Fat-free mass (FFM) and systolic blood pressure were the only modifiable risk factors positively associated with cIMT (e.g., mean difference in cIMT per 1-SD increase in FFM at age 17: 0.007 mm: 95% confidence interval [CI]: 0.004 to 0.010; p < 0.001), whereas fat mass was negatively associated with cIMT (difference: −0.0032; 95% CI: 0.004 to −0.001; p = 0.001). Similar results were obtained when investigating cumulative exposure to these factors throughout adolescence. An increase in cIMT maintained circumferential wall stress in the face of increased mean arterial pressure when increases in body mass were attributable to increased FFM, but not fat mass. Risk factor−associated differences in the radial artery occurred in the media alone, and there was little evidence of a relationship between intimal thickness and any risk factor.
Conclusions Subtle changes in cIMT in the young may predominantly involve the media and represent physiological adaptations as opposed to subclinical atherosclerosis. Other vascular measures might be more appropriate for the identification of arterial disease before adulthood.
Lifetime management of cardiovascular disease (CVD) risk factors is recognized as an important strategy for reducing future population burden of disease (1). In early life, the absence of clinical endpoints necessitates the use of intermediate cardiovascular phenotypes in population studies and clinical trials to understand the initiation and progression of early arterial disease and its response to interventions. Increased common carotid intima-media thickness (cIMT) is a well-established marker for future adverse CVD outcomes in older populations and certain clinical conditions (2) and is frequently also used in young population cohorts to link emerging CVD risk factors to the earliest development of subclinical atherosclerosis (3–6).
However, conventional cIMT is a composite measure of both intimal and medial layers and is therefore unable to determine whether changes in arterial wall thickness represent early atherosclerotic changes within the intimal layer, a remodeling response within the medial layer, or a combination of both. Although numerous studies have shown associations between well-established CV risk factors and cIMT (7), others have also reported associations with height, lean tissue mass, and vessel diameter (8–10), which suggests that physiological remodeling due to increased body size or growth may account for at least some of the changes commonly attributed to subclinical disease. These factors may be particularly relevant in the young, when cumulative exposure to CVD risk factors is low and comorbidities that increase atherosclerotic risk are largely absent.
Advances in ultra-high frequency ultrasound technology (UHFUS) now permit the individual layers of the arterial wall to be studied in detail (11–14). In an extensively phenotyped longitudinal cohort of healthy young people recruited to the ALSPAC (Avon Longitudinal Study of Parents and Children) trial, we combined this novel UHFUS technology in the radial artery with both cross-sectional and longitudinal analyses of cIMT to characterize the determinants of arterial wall changes in adolescence and young adulthood, and related these changes to other measures of carotid artery structure and biomechanical stress to identify potential adaptive and maladaptive changes at this age.
ALSPAC is a prospective birth cohort study investigating factors that influence normal childhood development and growth. The cohort and study design have been described in detail previously (15,16), and a brief description is provided in the Supplemental Appendix. Ethical approval for all aspects of this study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committee, and conformed to the Declaration of Helsinki. If the child was younger than age 16 years, informed written consent was obtained from the parent/guardian alongside assent from the child. When age 16 years or older, participants provided their own informed written consent.
Using a combination of both cross-sectional and longitudinal analyses from an age range spanning childhood (9 years) to young adulthood (21 years), we used 3 separate approaches to characterize determinants of IMT in a large cohort of young people free from clinical disease.
In 5,215 adolescents (mean age: 18 years) attending the ALSPAC Teen Focus 4 Clinic (ALSPAC@17), we investigated cross-sectional relationships between a range of CV risk factors (body composition, blood pressure [BP], lipids, insulin, glucose, inflammatory markers, lifestyle behaviors, and socioeconomic circumstances) and cIMT. In addition, we explored how these differences in cIMT were related to other measures of structure and stress within the carotid artery (lumen diameter, IMT/lumen ratio, and vessel circumferential wall stress).
Based on findings from the cross-sectional analysis, we next used repeat measures of body composition and BP in 4,561 participants (collected on 2 to 5 occasions between the ages of 9 and 17 years) to determine the effect of their cumulative exposure throughout adolescence on cIMT at 17 years.
Finally, further detailed phenotyping in 436 participants recalled at age 21 years allowed us to: 1) assess whether increased duration of exposure to risk factors in young adulthood altered relationships seen in adolescence; and 2) use UHFUS in a subsample of these participants to investigate the contribution of intimal and medial layers to arterial changes. Details of this cohort have been described previously (17), and a comparison of baseline characteristics between those who attended recall at age 21 years versus those who did not is shown in Supplemental Table 1.
Carotid artery structure and stress using high-frequency ultrasound
Common carotid artery lumen diameter, cIMT, and IMT/lumen ratio at age 17 and 21 years were assessed by ultrasound using a linear 12-MHz transducer (Vivid7, GE Medical, Chicago, Illinois) (18). Measurements were repeated for 3 different cardiac cycles and averaged. Interobserver variability for cIMT was assessed in a separate sample of 25 young adults (coefficient of variation: 4.4 ± 2.2%). Lumen diameter was calculated as external vessel diameter: (2 × cIMT). Mean circumferential wall stress (CWS; kPa) was calculated as: (mean arterial pressure × lumen diameter)/(2 × cIMT) (19).
Radial artery structure and stress using UHFUS
In a subsample of 172 participants (67% female) recruited at age 21 years, radial IMT and individual intimal and medial thicknesses were assessed by UHFUS using a linear MS700 30- to 70-MHz transducer (Vevo 2100, Fujifilm Visualsonics, Amsterdam, the Netherlands) with a scanning frequency of 50 MHz. Interobserver variability was assessed in a separate cohort of 10 young adults (coefficient of variation: 8.6 ± 3.7% and 8.5 ± 5.4% for radial IMT and medial thickness, respectively). Full details of the method and reproducibility were published elsewhere (12).
Cardiovascular risk factors
Body size and composition
At all ages, participant height (meters) was measured using a stadiometer (SECA 213, Birmingham, United Kingdom) and body mass (kilogram) using electronic weighing scales (Marsden M-110, Rotherham, United Kingdom). Body mass index (BMI) was calculated as body mass/height2. Body composition at ages 9, 11, 13, 15, and 17 years was assessed using a Lunar Prodigy DEXA scanner (GE Medical Systems, Madison, Wisconsin), whereas body composition at age 21 years was assessed using cardiac magnetic resonance (1.5T Avanto, Siemens Medical Solutions, New York, New York); details of both procedures were published previously (20,21). Fat-free mass (FFM) was calculated as body mass – fat mass (FM).
BP was measured on up to 6 occasions between the ages of 9 and 21 years (details in the Supplemental Appendix).
Metabolic risk factors
Blood samples (ALSPAC@17 fasting; ALSPAC@21 >4 to 6 h post-meal) were taken using standard procedures, immediately spun, separated, and frozen at –80 °C. Lipid profile (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), glucose, insulin, and C-reactive protein were measured as described previously (22).
Lifestyle risk factors
Socioeconomic class, smoking status, physical activity, dietary intake, and exposure to passive smoke exposure were included in analyses as potential confounders (details in the Supplemental Appendix).
Continuous data were summarized as mean ± SD or median (interquartile range) if skewed. In cross-sectional analyses at 17 and 21 years, multiple linear regression analyses were used to assess associations between a range of well-established CV risk factors and cIMT, and independent predictors were identified. All variables were converted to z-scores to allow comparisons between exposures. All multivariable models were inspected for collinearity and a variance inflation factor <5 was chosen as the threshold for acceptance. Multiple imputations (20 imputed datasets) were used to account for missing variables before analyses. Details of missing data at ages 17 and 21 years are shown in Supplemental Tables 2 and 3. To evaluate the effect of cumulative exposure to risk factors throughout adolescence and cIMT at age 17 years, we implemented latent class growth mixture modeling (LCGMM) analysis as previously described (23). By LCGMM, we characterized discrete patterns of FFM, FM, and systolic BP alterations from age 9 to 17 years. One to 5 classes were tested in LCGMM models, and selection was based on log-likelihood and Bayes information criterion indexes as well as posterior classification probabilities. Random intercept and slope(s) variance models were used in LCGMM analysis to flexibly model between-subjects heterogeneity in longitudinal changes in variables of interest. Linear, quadratic, and cubic specifications for the within-subject response of FFM, FM, and systolic BP as a function of age were tested (Supplemental Tables 4 to 6). z-Scores were used to enhance numeric stability and minimize differences between sexes. To account for interindividual growth differences, repeated measures were indexed to height squared. To test the effect of differing body compositions on arterial structural remodeling, multiple regression models were used to relate different ratios of FFM and FM to lumen diameter, cIMT, IMT/lumen ratio, and vessel CWS. Quartiles of FFM were assessed against each dependent variable while adjusting for FM and all other covariates, and then repeated using quartiles of FM. All analyses at age 21 years included additional adjustment for genetic recall groups due to the recall-by-genotype design of this sample, as described in detail elsewhere (17). Cross-sectional analyses were conducted using SPSS (version 22, IBM, Armonk, New York) or Stata (version 15, StataCorp, College Station, Texas). The “lcmm” package in RStudio (version 1.1.414, Boston, Massachusetts) was used in LCGMM analysis. All tests were 2-sided. A priori, we planned to draw conclusions based on effect estimates and their confidence intervals [CIs], rather than statistical tests using an arbitrary p value cutoff. For example, given 2 effects with the same point estimate—one with narrow CIs, the other with wider CIs that may even include the null—we described both as showing the same effect. However, one is more imprecisely estimated and should be treated with more caution until replicated in a larger sample. The use of “positive” and “inverse” throughout the text refer to directional association rather than clinical implication.
Participants in ALSPAC@17 were mean age of 17.8 ± 0.4 years and were 56% female, whereas those in ALSPAC@21 were on average 20.9 ± 1.0 years of age and 66% female. Other characteristics are shown in Table 1.
Cross-sectional associations between CV risk factors and cIMT
At age 17 years, FFM (mean difference in cIMT per 1-SD increase in exposure: 0.009 mm [95% CI: 0.008 to 0.010]; systolic BP difference: 0.007 mm [95% CI: 0.006 to 0.009]; physical activity level difference: 0.007 mm [95% CI: 0.005 to 0.008]; and dietary intake difference: 0.002 mm [95% CI: 0.004 to 0.006]) was found to be the modifiable risk factor positively correlated with cIMT, whereas FM (difference: −0.003 mm; 95% CI: −0.004 to −0.002) and C-reactive protein (difference: −0.002 mm; 95% CI: −0.004 to −0.001) were found to be negatively correlated (Table 2). Positive relationships were also seen for the nonmodifiable risk factors of male sex and height (Table 2). In a multivariable regression model that incorporated all significant univariate predictors, only male sex, FFM, and systolic BP remained positively associated with cIMT, whereas FM remained negatively associated (Table 2). Regression models conducted without multiple imputation were consistent with these findings (Supplemental Table 7). Results from the recall cohort at age 21 years (both in the cohort as a whole and in the subset with only UHFUS measures) showed similar effect sizes as those observed at age 17 years, albeit with wider 95% CIs due to the limited numbers of participants (Supplemental Table 8).
Cumulative exposure to CV risk factors throughout adolescence and cIMT
Based on the strong positive relationships between FFM and systolic BP with cIMT, and the negative relationship between FM and cIMT, longitudinal analyses were used to test relationships between cumulative exposure to these risk factors throughout adolescence and cIMT at age 17 years. To assess the impact of increased lean mass per se versus that of altering adiposity levels per se, 3 distinct trajectories of FFM and FM were identified by LCGMM analysis (Supplemental Figures 1 and 2). For FFM, most participants were classified as low exposure (n = 2,134), whereas the remaining participants were middle (n = 514) and high exposure (n = 1,913), respectively. Similarly, for FM changes, participants were classified as low (n = 905), middle (n = 2,250), and high exposures (n = 1,406). In fully adjusted models, including the aforementioned, covariates plus socioeconomic status, physical activity, smoking, exposure to second-hand smoke, and dietary intake, high exposure to FFM throughout adolescence was associated with greater cIMT at 17 years (mean difference in cIMT between low- and high-exposure groups: 0.008 mm; 95% CI: 0.002 to 0.015; p = 0.010) (Table 3). No interaction between sex and FFM exposure on cIMT at 17 years was observed (p = 0.245). By levels of adiposity, participants with the highest FM exposure (i.e., fattest participants) were found to have lower cIMT at 17 years (difference: −0.005 mm; 95% CI: −0.010 to 0.000; p = 0.037). In addition to cumulative exposures to different body compositions, 3 groups of cumulative exposure to systolic BP were also identified as follows: low (n = 3,580), middle (n = 556), and high systolic BP (n = 421) (Supplemental Figure 3). Having high systolic BP across adolescence was associated with increased cIMT at 17 years (mean difference in cIMT in high-exposure group compared with low-exposure group: 0.007 mm; 95% CI: 0.001 to 0.012; p = 0.017). Findings from regression models without imputation for missing values were consistent with these results (Supplemental Table 9).
Cross-sectional associations between body composition and carotid artery structure and stress
Due to the opposite associations observed for FFM (positive) and FM (negative) with cIMT, we assessed differences in carotid artery remodeling with increasing FFM (i.e., growth), or with increased FM (i.e., adiposity). Growth was associated with equivalent increases in both cIMT and lumen diameter, which resulted in an unchanged IMT/lumen ratio and a preserved vessel CWS in the face of increased mean arterial pressure. In contrast, increasing adiposity was associated with an increased carotid lumen diameter, but a reduced cIMT, which resulted in a reduced IMT/lumen ratio and progressively increased CWS as levels of FM and mean arterial pressure increased (Figure 1). Similar results were observed at age 21 years, with elevated levels of FFM associated with similar increases in lumen diameter and cIMT, and therefore, preserved CWS, whereas increased FM showed a trend for increased lumen diameter, decreased IMT, and a progressive increase in CWS (Supplemental Figure 4).
Associations between CV risk factors and individual intimal and medial layers within the radial artery
Radial IMT at age 21 years showed similar relationships to FFM and FM as those observed for cIMT at both 17 and 21 years (Supplemental Figure 5). When assessing the impact of growth and adiposity on intimal and medial layers separately, increases in radial IMT were attributable to an increase in media thickness, with intimal thickness unchanged in relation to growth (Supplemental Figure 6). Similar to cIMT at this age, we found little evidence of a relationship between increased adiposity and thickening in either the medial or intimal layer (Supplemental Figure 6). In models adjusted for age, sex, and height, media thickness was found to be associated with changes in body composition (FFM and FM) and BP (systolic BP and diastolic BP) (Figure 2). In contrast to findings in the medial layer, we did not observe any evidence of a relationship between any measure of body composition (FFM or FM), BP, lipids (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), glucose homeostasis (glucose, insulin), or inflammatory (C-reactive protein) risk factors with intima thickness (Figure 2).
Our study suggested that subtle differences in cIMT commonly observed in adolescents and young adults are likely to represent arterial remodeling in response to increased levels of FFM and BP, rather than being an early marker of intimal disease. A number of findings supported this hypothesis. First, we showed that increases in FFM were independently associated with increases in both carotid cIMT and lumen diameter, thereby maintaining the arterial IMT/lumen ratio and CWS despite increases in BP and vessel diameter. Second, using longitudinal measures of body composition collected between the ages of 10 and 17 years, we found that those with the highest cumulative exposure to FFM and systolic BP throughout adolescence had the greatest cIMT at age 17 years, whereas those with the highest relative adiposity (i.e., highest absolute FM) displayed the opposite. Finally, using novel UHFUS technology, we demonstrated that FFM-related changes in cIMT were mirrored in the radial artery. These changes occurred in the medial layer alone and were associated with body composition and BP. We also found little evidence of an association between intimal thickness and any measured CV risk factor.
cIMT is a well-established risk marker for atherosclerosis―although its use is not recommended in clinical guidelines for risk stratification―has been shown to predict future cardiovascular events independently of traditional risk factors in adults (2,23,24). Due to a lack of clinical events in the young, studies in children and adolescents, such as a recent study in metabolically healthy and unhealthy individuals ages 6 to 17 years of age (25), commonly use cIMT as a surrogate endpoint linking early CVD risk factor exposure to subclinical atherosclerotic disease (3–6,26). However, whether cIMT truly reflects the earliest indication of intimal disease or is largely a reflection of other growth-related changes in arterial morphology, has never been rigorously investigated. Using a large and extensively phenotyped longitudinal cohort, we showed in both cross-sectional and prospective analyses that higher FFM was the predominant factor that explained the subtle increases in cIMT in young adulthood. These findings supported recently published work that related body composition to numerous subclinical markers of disease in the Southampton Women’s Study, in which the lean mass index, but not the FM index, was found to predict cIMT in healthy 8- to 9-year-old children (10), as well as in a number of smaller adult studies, where FFM was found to explain much of the obesity-related variance in cIMT (8,9). Increases in FFM in the present study were found to be positively associated with both carotid lumen diameter and cIMT, which resulted in the maintenance of the IMT/lumen ratio and a preservation of vessel CWS when increases in body mass consisted of lean tissues. Use of UHFUS in the radial artery identified these changes as being confined to the medial layer of the vessel wall alone. This suggested that subtle changes in cIMT often attributed to excess adiposity in the young were likely to represent an anatomical remodeling response to an underlying accumulation of FFM and an increase in SBP, rather than the development of intimal disease in relation to excess FM and its associated cardiometabolic risk factors.
The relationship between FFM and cIMT at this age is likely partially mediated by increases in systolic BP that accompany accumulation of FFM. It is well-established that the high metabolic demands of lean tissue accumulation necessitate a chronic increase in blood flow. This requirement is met through stroke volume−driven increases in cardiac output (17), which, in turn elevates BP. Previous research in adults (26,27) showed systolic BP to be the component of BP most strongly associated with cIMT. We replicated this observation in young people and expanded on it by identifying the medial layer as the site of thickening when FFM increases at this age. In contrast to FFM, neither FM nor its related CV risk factors (diastolic BP, lipids, glucose) were associated with vessel wall thickening once FFM was accounted for, with increasing FM levels instead associated with decreased cIMT at age 17 years. Consequently, participants with greater levels of adiposity had progressive increases in vessel CWS as both diameter and MAP were increased and wall thickness was decreased. Although not tested in this study, this cumulative exposure to increased wall stress likely increased fractional collagen (rather than elastin) engagement within the vessel wall, leading to progressive stiffening of the major elastic arteries over time. These changes, combined with high levels of circulating metabolic risk factors, might confer long-term damage to the vasculature. Overall, our data suggested that the subtle increases in cIMT observed at this age in association with FFM may potentially represent a protective remodeling response within the vessel media, rather than the initial signs of atherosclerosis.
It is important to note that our findings were derived from a young predominantly healthy population cohort and did not imply that cIMT is an unsuitable surrogate marker for subclinical atherosclerotic disease in other clinical populations, either young or old. Although we propose that subtle changes in cIMT at this age were likely to reflect FFM-related arterial remodeling, several studies suggested that more pronounced arterial wall thickening in older or unhealthy populations with more complex risk factor profiles were likely to be pathological. First, although cIMT was found to be predominantly related to body size (BMI and/or waist/hip ratio) and BP (SBP and pulse pressure) in adolescence (11 to 17 years) in a study of 635 healthy adolescents and young adults taking part in the Muscatine Offspring Study, additional independent associations for numerous other established CVD risk factors (total cholesterol, low-density lipoprotein cholesterol, triglycerides, and glycosylated hemoglobin) began to emerge when the same analyses were carried out in an older age group (18 to 34 years) with more pronounced changes in cIMT (28). Second, both genetic and observational studies from the slightly older Cardiovascular Risk in Young Finns cohort reported positive relationships between longitudinal measures of BMI and changes in cIMT at age 24 to 39 years (29). This suggested that extended cumulative exposure to CV risk factors (e.g. elevated lipids, inflammation, and so on) might be critical in the development of arterial damage in later adulthood. Finally, using UHFUS in children with chronic kidney disease, our group previously demonstrated differential remodeling of the radial artery wall compared with healthy individuals. This pathological response was characterized by pronounced medial thickening in tandem with elevated serum phosphate levels that resolved following renal transplantation, which suggested an adverse influence of the uremic milieu on vessel structure (14). Future studies using UFHUS in other high-risk adolescent groups (e.g., familial hypercholesterolemia or diabetes) might help to highlight the underlying wall layers driving IMT in different pathological states.
This study had strengths and limitations. The observational nature of our findings prevented us from inferring causal relationships between exposures and outcomes. However, our findings built upon a recent Mendelian randomization study of this cohort that did not observe a causal relationship between BMI and cIMT (17). Access to one of the world’s largest and most extensively phenotyped longitudinal birth cohorts (ALSPAC) allowed us to conduct both cross-sectional and prospective analyses while adjusting for a wide range of sociodemographic, health-related, and lifestyle factors, thereby minimizing the potential for undetected confounding. Although a higher response rate from females in ALSPAC@21 might have affected results, we attempted to account for this in statistical models, and our findings in this group were consistent with those at age 17 years. The use of a novel UHFUS technique in a subset of these participants allowed us to explore the anatomical changes underlying increases in IMT that could not be detected using traditional ultrasound techniques. A potential limitation of UHFUS was the limited penetration depth of the ultrasound signal (approximately 1 cm), which required us to use a peripheral radial artery rather than the gold standard carotid artery for these tests. Research using UHFUS in older participants showed radial artery measures offered the same predictive risk for coronary heart disease compared with carotid measures (13). Although the possibility exists that different vessels might not respond to risk factors in the same way in the young, the virtually identical effect sizes between FFM and both cIMT (at age 17 and 21 years) and radial IMT (at age 21 years) suggested similar remodeling responses (Supplemental Figures 5, Supplemental Table 8). Although the preservation of CWS suggested that this remodeling was predominantly adaptive in nature, we could not rule out the presence of an early pathological response to increased BP because of its known impact on future disease risk. Finally, although systematic differences across the follow-up period of the study were taken into consideration by age and/or study year−specific values in LCGMM analysis, the potential for residual bias in BP analyses due to the different methodologies and/or equipment used at each clinic visit could not be excluded. In addition, despite efficient latent class separation and satisfactory fitting to observed data for measures of FFM, FM, and systolic BP, residual within-group variability that was not accounted for might still exist.
These findings suggest that subtle changes in cIMT in young healthy populations may predominantly represent physiological adaptation to differing levels of FFM as opposed to evidence of intimal disease and signs of early subclinical atherosclerosis (Central Illustration). As a result, increases in cIMT should be interpreted with caution before adulthood. Other vascular measures may potentially be more appropriate for the identification of early arterial disease at this age.
COMPETENCY IN MEDICAL KNOWLEDGE: Subtle changes in cIMT in young healthy populations appear to be confined to the medial layer and may predominantly represent physiological adaptation to differing levels of FFM mass rather than evidence of intimal disease and signs of early subclinical atherosclerosis.
TRANSLATIONAL OUTLOOK: These findings are derived from a young and healthy population cohort free from established clinical disease. Additional studies are needed to establish whether the evolution of cIMT differs in individuals with differing risk factor profiles (e.g., young people with diabetes, familial hypercholesterolemia, and so on). Until such time, increases in cIMT should be interpreted with caution before adulthood.
The authors are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses.
This research was funded through grants from the British Heart Foundation (RG/10/004/28240, PG/06/145, and CS/15/6/31468), University of Bristol, and UK Medical Research Council and Wellcome Trust (102215/2/13/2, MC_UU_12013/1–9, 096989/Z11/Z, and 086676/7/08/Z). Dr. Deanfield was supported by the British Heart Fund. Dr. Timpson was supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-20011) and the MRC Integrative Epidemiology Unit (MC_UU_12013/3). Drs. Davey Smith and Lawlor work in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/6). Dr. Lawlor has received support from Medtronic and Roche Diagnostics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Abbreviations and Acronyms
- body mass index
- blood pressure
- confidence intervals
- common carotid artery intima-media thickness
- cardiovascular disease
- circumferential wall stress
- fat-free mass
- fat mass
- latent class growth mixture modelling
- ultra-high frequency ultrasound technology
- Received July 8, 2019.
- Revision received August 26, 2019.
- Accepted August 28, 2019.
- 2019 The Authors
- JBS3 Board
- Meyer A.A.,
- Kundt G.,
- Steiner M.,
- Schuff-Werner P.,
- Kienast W.
- Sletner L.,
- Mahon P.,
- Crozier S.R.,
- et al.
- Osika W.,
- Dangardt F.,
- Grönros J.,
- et al.
- Wade K.H.,
- Chiesa S.T.,
- Hughes A.D.,
- et al.
- Frysz M.,
- Deere K.,
- Lawlor D.A.,
- Benfield L.,
- Tobias J.H.,
- Gregson C.L.
- Riddoch C.J.,
- Leary S.D.,
- Ness A.R.,
- et al.
- Bots M.L.,
- Hoes A.W.,
- Koudstaal P.J.,
- Hofman A.,
- Grobbee D.E.
- Zhao M.,
- López-Bermejo A.,
- Caserta C.A.,
- et al.
- Zanchetti A.,
- Crepaldi G.,
- Bond M.G.,
- et al.
- Ferreira J.P.,
- Girerd N.,
- Bozec E.,
- et al.
- Dawson J.D.,
- Sonka M.,
- Blecha M.B.,
- Lin W.,
- Davis P.H.